Recent scientific reports featuring contributions from our scientists and selected members of the drug discovery community.
Annual Report and Consolidated Financial Statement For the Year Ended 31 March 2024
Fostering a Dynamic, Sustainable Medicines Discovery Sector’ reveals the extent of the sector’s challenges
Vascular dementia (VaD) is the second most common form of dementia after Alzheimer’s Disease and its prevalence increases with age.
MDC is developing new ways to characterise the physical properties of nanoparticles using single molecule localisation microscopy.
The level of research activity undertaken globally into the causes of amyotrophic lateral sclerosis has dramatically expanded in recent years, resulting in the identification of multiple genetic risk factors, cellular pathways, and potential drug targets.
A defining pathological feature of human lung fibrosis is localized tissue heterogeneity, which challenges the interpretation of transcriptomic studies that typically lose spatial information.
Consensus Workshop | Medicines Discovery Catapult, My Name’5 Doddie Foundation and the MND Association
See how we can help support you with your next drug discovery project.
Speak to us
